Lines of Business (Tables)

6 Months Ended

Jun. 30, 2014

Segment Reporting [Abstract]

Lines of Business

The following is a summary of certain financial data for each of our segments (in thousands):

	Animal Hospital			Laboratory			All Other		Corporate			Eliminations			Total
Three Months Ended June 30, 2014
External revenue	$	386,776		$	81,320		$	20,457	$	—		$	919		$	489,472
Intercompany revenue	—			14,635			3,255		—			(17,890		)	—
Total revenue	386,776			95,955			23,712		—			(16,971		)	489,472
Direct costs	323,440			46,863			16,064		—			(17,310		)	369,057
Gross profit	63,336			49,092			7,648		—			339			120,415
Selling, general and administrative expense	9,864			8,281			7,411		14,375			—			39,931
Operating income (loss) before sale or disposal of assets	53,472			40,811			237		(14,375		)	339			80,484
Net loss (gain) on sale or disposal of assets	414			(7		)	97		74			—			578
Operating income (loss)	$	53,058		$	40,818		$	140	$	(14,449	)	$	339		$	79,906
Depreciation and amortization	$	15,110		$	2,563		$	2,004	$	826		$	(473	)	$	20,030
Capital expenditures	$	8,119		$	1,304		$	920	$	1,333		$	(316	)	$	11,360
Three Months Ended June 30, 2013
External revenue	$	365,205		$	76,949		$	22,229	$	—		$	872		$	465,255
Intercompany revenue	—			14,281			5,243		—			(19,524		)	—
Total revenue	365,205			91,230			27,472		—			(18,652		)	465,255
Direct costs	305,092			46,004			18,049		—			(18,184		)	350,961
Gross profit	60,113			45,226			9,423		—			(468		)	114,294
Selling, general and administrative expense	8,720			7,965			8,041		14,297			—			39,023
Operating income (loss) before sale or disposal of assets	51,393			37,261			1,382		(14,297		)	(468		)	75,271
Net (gain) loss on sale or disposal of assets	(160		)	(1		)	1		(270		)	—			(430		)
Operating income (loss)	$	51,553		$	37,262		$	1,381	$	(14,027	)	$	(468	)	$	75,701
Depreciation and amortization	$	14,684		$	2,590		$	1,937	$	735		$	(446	)	$	19,500
Capital expenditures	$	11,326		$	1,818		$	1,039	$	1,306		$	(363	)	$	15,126

8. Lines of Business, continued

	Animal Hospital		Laboratory			All Other			Corporate			Intercompany Eliminations			Total
Six Months Ended June 30, 2014
External revenue	$	738,364	$	156,103		$	42,658		$	—		$	1,854		$	938,979
Intercompany revenue	—		28,386			9,175			—			(37,561		)	—
Total revenue	738,364		184,489			51,833			—			(35,707		)	938,979
Direct costs	626,228		92,366			34,216			—			(35,697		)	717,113
Gross profit	112,136		92,123			17,617			—			(10		)	221,866
Selling, general and administrative expense	18,992		16,299			15,759			30,321			—			81,371
Operating income (loss) before sale or disposal of assets	93,144		75,824			1,858			(30,321		)	(10		)	140,495
Net loss (gain) on sale and disposal of assets	582		(78		)	(1,087		)	(60		)	—			(643		)
Operating income (loss)	$	92,562	$	75,902		$	2,945		$	(30,261	)	$	(10	)	$	141,138
Depreciation and amortization	$	29,852	$	5,098		$	4,140		$	1,645		$	(938	)	$	39,797
Capital expenditures	$	21,187	$	3,285		$	1,678		$	2,744		$	(915	)	$	27,979
Six Months Ended June 30, 2013
External revenue	$	705,820	$	150,588		$	45,856		$	—		$	1,597		$	903,861
Intercompany revenue	—		27,977			10,139			—			(38,116		)	—
Total revenue	705,820		178,565			55,995			—			(36,519		)	903,861
Direct costs	600,508		90,874			36,938			—			(35,676		)	692,644
Gross profit	105,312		87,691			19,057			—			(843		)	211,217
Selling, general and administrative expense	17,045		15,970			16,955			28,899			—			78,869
Operating income (loss) before sale or disposal of assets	88,267		71,721			2,102			(28,899		)	(843		)	132,348
Net loss (gain) on sale and disposal of assets	1,569		(6		)	3			(270		)	—			1,296
Operating income (loss)	$	86,698	$	71,727		$	2,099		$	(28,629	)	$	(843	)	$	131,052
Depreciation and amortization	$	28,071	$	5,097		$	3,902		$	1,554		$	(885	)	$	37,739
Capital expenditures	$	25,767	$	3,736		$	2,372		$	1,946		$	(726	)	$	33,095
At June 30, 2014
Total assets	$	1,880,805	$	261,786		$	87,548		$	133,975		$	(104,876	)	$	2,259,238
At December 31, 2013
Total assets	$	1,854,609	$	247,591		$	96,245		$	77,153		$	(37,817	)	$	2,237,781